Here is an article about Gentell’s acquisition of Manukamed:
Gentell Expands Global Wound Care Reach with Acquisition of New Zealand’s Manukamed
WAYNE, PA – July 14, 2025 – Gentell, a leading provider of advanced wound care solutions, is pleased to announce the strategic acquisition of Manukamed, a distinguished New Zealand-based manufacturer and distributor of innovative wound care products. This significant development marks a pivotal moment for Gentell, further strengthening its global presence and expanding its comprehensive portfolio of high-quality wound management offerings.
The integration of Manukamed into Gentell’s global network is set to enhance the accessibility of advanced wound care solutions for healthcare professionals and patients across a wider geographical region. Manukamed has established a strong reputation for its commitment to quality and innovation, particularly within the ANZ (Australia and New Zealand) market. Their product lines are well-regarded for their efficacy in addressing a range of wound complexities, aligning seamlessly with Gentell’s mission to provide cutting-edge treatments that promote healing and improve patient outcomes.
This acquisition represents a synergistic partnership, combining Gentell’s extensive experience in wound care manufacturing and distribution with Manukamed’s established regional expertise and product portfolio. By joining forces, both companies are poised to leverage their combined strengths to drive further innovation in wound care technology and deliver even greater value to the global healthcare community.
“We are delighted to welcome Manukamed to the Gentell family,” stated [Name and Title of Gentell Spokesperson, if available in the source]. “This acquisition is a significant step in our ongoing commitment to expanding our global footprint and providing best-in-class wound care solutions to underserved markets. Manukamed’s dedication to quality and their deep understanding of the ANZ healthcare landscape make them an ideal partner for Gentell. Together, we will be able to offer a more comprehensive range of products and services, ultimately benefiting patients and clinicians alike.”
Manukamed’s product offerings are expected to complement Gentell’s existing range, creating a more robust and diverse selection of wound care treatments. This expansion will enable Gentell to better cater to the specific needs and preferences of healthcare providers in New Zealand and Australia, while also providing a strong platform for further growth within the broader Asia-Pacific region.
The company anticipates a smooth integration process, focusing on retaining the high standards of quality and customer service that both Gentell and Manukamed are known for. This strategic move underscores Gentell’s dedication to advancing the field of wound care through strategic partnerships and continuous innovation.
AI has delivered the news.
The answer to the following question is obtained from Google Gemini.
www.prnewswire.com published ‘GENTELL ADDS NEW ZEALAND’S, MANUKAMED, TO ITS GLOBAL PORTFOLIO OF WOUND CARE MANUFACTURING AND DISTRIBUTION’ at 2025-07-14 15:14. Please write a detailed article about this news in a polite tone with relevant information. Please reply in English with the article only.